Preview

Siberian Journal of Clinical and Experimental Medicine

Advanced search

Damage, inflammation of the vascular endothelium, hypercoagulable as a risk factor for heart diseases in patients with chronic alcoholism

https://doi.org/10.29001/2073-8552-2014-29-4-52-55

Abstract

The study examined the markers of damage and inflammation of the vascular wall and abnormal blood coagulation in 60 patients with chronic alcoholism stage II (heavy drinkers). High-sensitive CRP (hsCRP) levels were measured by immunoturbidimetric assay with Termo Fisher reagents (Finland) and automatic biochemical analyzer Konelab 60i (Thermo Electron, Finland). Homocysteine was determined by ELISA by using Axis-Shield test system (Germany, Norway). The functional activity of von Willebrand factor (vWF) was determined by measuring ristomycin-cofactor activity (RSA) of blood plasma with Renamo test system (Russia). Level of vWF antigens were quantitively measured by ELISA with Technoclone test system (USA). Activated partial thrombin time (APTT) was determined with Platelin LS reagent (Organon Teknika Corporation). Data showed the increases in the level and activity of vWF (р<0.001) and in the levels of homocysteine (р<0.001) suggesting the damage to the vascular endothelium. The level of HsSRB increased by 3.8 times compared to healthy individuals (p<0.001) suggesting the presence of chronic indolent inflammation of the intima of the arterial wall. Decrease of aPTT (p=0.01) indicated hypercoagulability in patients with chronic alcoholism stage II. Positive correlation was found between homocysteine concentration and vWF level (r=0.46; p <0.001), homocysteine level and vWF activity (r=0.62; p<0.001), and between homocysteine and NsSRB levels (r=0.59; p<0.001). Inverse correlation was documented between APTT and vWF activity (p=0.01; r=-0.34) and homocysteine level (p=0.03; r=-0.36). In summary, hyperhomocysteinemia and increased VWF activity were accompanied by hypercoagulability in patients with chronic alcoholism stage II presented with high risk of cardiovascular diseases.

About the Authors

A. M. Koriakin
Novokuznetsk Institute of Continuing Medical Education
Russian Federation


N. N. Epifantseva
Novokuznetsk Institute of Continuing Medical Education
Russian Federation


L. A. Eshcheva
Novokuznetsk Institute of Continuing Medical Education
Russian Federation


L. A. Dementjeva
Novokuznetsk Institute of Continuing Medical Education
Russian Federation


A. V. Yakimovskikh
Novokuznetsk Institute of Continuing Medical Education
Russian Federation


References

1. Вавилова Т.В. Гемостазиология в клинической практике: пособие для врачей. - СПб.: Изд-во СПбГМУ им. акад. И.П. Павлова, 2005. - 92 с.

2. Корякин А.М., Епифанцева Н.Н., Дадыка И.В. и др. Гомоцистеин и фактор Виллебранда при хроническом алкоголизме // Клин. лаб. диагн. - 2010. - № 4. - С. 5-7.

3. Корякин А.М., Дадыка И.В., Епифанцева Н.Н. и др. С-реактивный белок и другие белки острой фазы воспаления у больных хроническим алкоголизмом // Сибирский медицинский журнал (Томск). - 2007. - № 2.- С. 38-39.

4. Папаян Л.П. Современные представления о механизмах регуляции свертывания крови // Тромбоз, гемостаз и реология. - 2003. - № 2. - С. 7-11.

5. Пауков В.С., Беляева Н.Ю., Воронина Т.М. Алкоголизм и алкогольная болезнь // Тер. архив. - 2001. - № 2. - С. 65-67.

6. Шевченко О.П. Высокочувствительный анализ С-реактивного белка и его применение в кардиологии // Лаб. мед. -2003. - № 6. - С. 35-41.

7. Di Castelnuova A., Costanzo S., Bagnardi V. et al. Alcohol dosing and total mortality in men and women: an updated metaanalysis of 34 prospective studies // Arch. Intern. Med. - 2006. - Vol. 166, No. 22. - P. 2437-2445.

8. Friesema I.H., Zwietering P.J., Veenstra M.Y. et al. Alcohol intake and cardiovascular diseases and mortality: the role of preexisting disease // J. Epidemiol. Community Health. - 2007. -Vol. 61, No. 5. - P. 441-446.

9. Gibson A., Woodside J.V., Young I.S. et al. Alcohol increases homocystein and reduces B vitamin concentration in healthy male volunteers randomized, crossover intervention study // QJM. - 2008. - Vol. 101, No. 11. - P. 881-887.

10. Klatsky A.L. Alcohol and cardiovascular diseases // Expert Rev. Cardiovasc. Ther. - 2009. - Vol. 7, No. 5. - P. 499-506.

11. Mukamal K.J., Jadhav P.P., D’Agostino R.B. et al. Clinical investigation and reports. Alcohol consumption and hemostatic factors. Analysis of the Framingham offspring cohort // Circulation. - 2001. - Vol. 104. - P. 1367-1373.

12. Peason J.D. Markers of endothelial cell perturbation and damage // Brit. J. Reumatology. - 1993. - Vol. 32. - P. 651-652.

13. Pitsavos C., Panaqiotakos D.B., Kontoqianni M.D. et al. The J-shape association of ethanol intake with total homocystein concentrations: the ATTICa study // Nutr. Metab. - 2004, Oct. 14. - P. 1(1)-9.

14. Peason T.A., Mensah G.A., Wayne A.R. et al. Markers of inflammation and cardiovascular disease. Application to clinical and public health practice. A statement for disease control and prevention and American Heart Association // Circulation. -2003. - Vol. 107. - P. 499-511.

15. Undas A., Williams B., Butenas S. et al. Homocystein inhibits inactivation of the factor Va by activated protein C // G. Biol. Chem. - 2001. - Vol. 276; Issue 6. - P. 4389-4397.


Review

For citations:


Koriakin A.M., Epifantseva N.N., Eshcheva L.A., Dementjeva L.A., Yakimovskikh A.V. Damage, inflammation of the vascular endothelium, hypercoagulable as a risk factor for heart diseases in patients with chronic alcoholism. Siberian Journal of Clinical and Experimental Medicine. 2014;29(4):52-55. (In Russ.) https://doi.org/10.29001/2073-8552-2014-29-4-52-55

Views: 373


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2713-2927 (Print)
ISSN 2713-265X (Online)